Harbor Compounding Pharmacy Costa Mesa: Which Address Is Real?

Introduction: Why “Harbor Compounding Pharmacy Costa Mesa” Returns Two Different Answers

Anyone searching for Harbor Compounding Pharmacy in Costa Mesa quickly runs into a problem: the internet offers two different physical addresses for the same business. Depending on which directory, map, or review site a person checks, the pharmacy appears to be located in either Costa Mesa or Santa Ana.

This article is a verification guide. It is not a generic locator listing or a broad “how to choose a pharmacy” explainer. Its goal is to lay out the conflicting information, explain where each version comes from, and give patients a clear way to confirm the correct details before acting.

The two addresses in dispute are:

• 2000 Harbor Blvd, Ste C-100, Costa Mesa, CA 92627, the legacy address still used by many major directories
• 3500 W Lake Center Drive, Unit B, Santa Ana, CA 92704, the address on Harbor’s own current contact page

Both locations share the same phone number, (949) 642-0106. That shared number adds to the confusion rather than resolving it.

The stakes go beyond convenience. Patients sending prescriptions, insurance paperwork, or lab results, or planning an in-person visit, need the correct dispensing address. Accreditation and regulatory status also affect how much trust a patient can place in what is being compounded. The sections below cover the address conflict, Harbor’s accreditation history (including a PCAB lapse and a later NABP accreditation), California’s compounding rule change that took effect in October 2025, and a transparent note on where Nationwide Compounding Rx® fits into this picture.

The Two Addresses, Side by Side

Before analyzing the discrepancy, it helps to see both data points clearly.

Detail	Legacy Listing	Current Listing
Address	2000 Harbor Blvd, Ste C-100, Costa Mesa, CA 92627	3500 W Lake Center Drive, Unit B, Santa Ana, CA 92704
Phone	(949) 642-0106	(949) 642-0106
Primary source	Third-party directories	Harbor’s official contact page
Likely status	Historical headquarters	Current operational address

The Legacy Listing: 2000 Harbor Blvd, Ste C-100, Costa Mesa, CA 92627

A long list of third-party platforms still cites the Costa Mesa address, including Healthgrades, the Better Business Bureau (BBB), RxLocal, RxLess, MapQuest, Wellness.com, and Manta.

Business data aggregator ZoomInfo also ties the company to this suite, estimating Harbor Compounding Pharmacy’s revenue at roughly $16.5 million with 51 to 200 employees, headquartered at 2000 Harbor Blvd Ste C100 in Costa Mesa.

Yelp’s business profile likewise remains filed under a Costa Mesa listing name, even though many reviews reference the pharmacy shipping medications to customers in other locations.

This address appears to be where the company was historically headquartered. Harbor describes its origin story as dating to the early 1990s, when it began offering customized medications focused on hormone rebalancing, nutrition, and detoxification. A business with that kind of history naturally accumulates a large digital footprint tied to its original location.

The Current Listing: 3500 W Lake Center Drive, Unit B, Santa Ana, CA 92704

The Santa Ana address is the one listed on Harbor’s own current contact page. As a general rule, a business’s official website is the most authoritative source for its active location, since the business controls that information directly.

The shared phone number, (949) 642-0106, strongly suggests that these listings represent one operational business, not two separate pharmacies. A practical explanation is that the company relocated or consolidated operations to Santa Ana while legacy directory listings were never updated. This is a common issue for healthcare businesses with long online histories.

The reasonable conclusion is this: readers should treat the pharmacy’s own current contact page as the more reliable source for an active mailing or dispensing address. Even so, a direct phone call to confirm the address before mailing any documents remains the safest step.

Why the Discrepancy Likely Exists: A Brief Business History

BBB records show the registered entity as “Harbor Compounding & Home Health Care Pharmacy,” with the alternate names Creative Compounds Inc and Harbor Compounding Pharmacy. The listed business start date is May 4, 2010, and Michael Can Hua is named as President.

Pharmacies that have operated for more than a decade often relocate, consolidate facilities, or change registered details without fully cleaning up outdated directory citations. Directory sites frequently scrape and republish older data, so a single outdated record can echo across dozens of platforms for years.

This is a widespread problem in local healthcare search visibility and is not, by itself, evidence of anything improper. It does, however, create real friction for patients trying to figure out where to send a prescription. That friction is exactly why sourced verification resources serve a different purpose than thin directory listings, which typically show only a name, address, and phone number with no context.

The Accreditation Question: PCAB vs. NABP

Accreditation matters because it signals that an independent body has reviewed a pharmacy’s compounding quality, sterility practices, and staff competency. For patients receiving custom-made medications, which are not FDA-approved as finished products, accreditation is one of the few outside indicators of quality available.

Harbor’s PCAB History and Its 2018 Lapse

According to a PR Newswire release, Harbor earned accreditation from the Pharmacy Compounding Accreditation Board (PCAB) in December 2012, and a later approval extended that accreditation through December 11, 2018. Public PCAB renewal records indicate the accreditation was not renewed after that date.

There is an inconsistency worth noting. Harbor’s own “Choosing the Right Compounding Pharmacy” page still states: “We have been PCAB accredited since 2012 and are still to this day.” That language conflicts with the lapsed renewal record.

This is best understood as outdated web copy that has not been addressed rather than as an accusation of wrongdoing. Still, it represents a trust gap that patients doing due diligence should be aware of.

The Shift to NABP Accreditation

In March 2022, Harbor announced that it had received Compounding Pharmacy Accreditation from the National Association of Boards of Pharmacy (NABP). This represents a shift away from the PCAB branding that still appears in some of its older materials.

NABP accreditation generally verifies that a pharmacy meets defined safety, quality, and operational standards, serving a role broadly comparable to PCAB. The key takeaway for patients is simple: ask the pharmacy directly for current, verifiable accreditation documentation rather than relying on legacy badges or older web pages.

For context, Nationwide Compounding Rx® holds current PCAB accreditation. That detail is included here as educational context to illustrate what current accreditation looks like, not as a sales pitch.

California’s October 2025 Compounding Rule Change: What It Means Right Now

California’s Board of Pharmacy adopted new compounding regulations that took effect on October 1, 2025. One of the most significant changes is a revised definition of what counts as “essentially a copy” of a commercially available drug.

Under the new standard, pharmacists must verify and document a “clinically significant difference” for an identified patient before compounding a preparation that resembles a commercial product. This is stricter than federal 503A law, and it applies to both sterile and non-sterile compounding.

For Orange County patients, the practical implications include:

• More documentation may be required before a compounded prescription, such as hormone therapy or a pediatric formulation, can be filled.
• Pharmacists carry an affirmative duty to verify and document the clinical rationale, a burden not present under federal law alone.
• Prescribers may be contacted for additional information supporting medical necessity.

This creates a new and timely due-diligence question for anyone filling a compounded prescription in California in late 2025: “Has my pharmacy adapted its documentation process to this rule?”

Pharmacists and patients who want full regulatory detail should consult the California Board of Pharmacy’s own Compounding Regulations FAQ document, which is the authoritative source on these requirements.

What Patients and Families Should Actually Do: A Verification Checklist

The information above is useful only if it leads to clear action. The following checklist turns it into practical steps.

Before Calling or Visiting

1. Call (949) 642-0106 directly to confirm the current dispensing and mailing address before sending any paperwork or prescriptions.
2. Ask which address handles which function. Compounding pharmacies sometimes separate lab or dispensing operations from mailing addresses, so ask explicitly which address to use for patient correspondence and which for walk-in service.
3. Request current accreditation documentation, whether PCAB or NABP, rather than relying on website claims alone.
4. Ask about California compliance. Find out how the pharmacy is meeting the October 2025 “clinically significant difference” documentation requirement for the specific type of prescription being filled.

Setting Realistic Expectations From Reviews

Harbor’s Yelp profile shows a 4.7-star rating across 132 reviews, with highlights praising prompt communication and reliable shipping for out-of-state customers. That is a strong signal of customer loyalty.

Reviews are not uniformly positive, however. One 2023 reviewer noted that compounded bioidentical hormone prices were “much higher than other pharmacies.” Given this known friction point, patients should ask about pricing and insurance coverage upfront rather than assuming cost parity with retail pharmacies.

For context, Harbor’s core specialties include:

• Bioidentical hormone replacement therapy
• Compounded pediatric medicines
• Pain therapies
• Custom thyroid prescriptions
• Veterinary formulations
• Dermatological preparations

An Honest Disclosure: Why Nationwide Compounding Rx Cannot Simply Recommend a Switch

Nationwide Compounding Rx® does not currently ship to California, due in part to the stricter regulatory requirements the state imposes on compounding pharmacies, including rules such as California’s new documentation standard.

This disclosure matters. A pharmacy willing to say “we can’t help you directly” earns more credibility than one offering a vague workaround. For Costa Mesa and Orange County readers right now, it is the only honest answer. It also confirms the purpose of this article: to educate and verify, not to deliver a disguised sales pitch. Transparency is the trust signal.

Who Nationwide Compounding Rx Can Actually Help

Nationwide Compounding Rx®, based in Scottsdale, Arizona, ships to patients and providers across the majority of U.S. states, with coverage varying by medication type and state licensing requirements. That footprint makes it a relevant resource for readers outside California or those who may relocate.

Audiences who may benefit include:

• Multi-state healthcare providers evaluating compounding partners for patients outside California
• Out-of-state family members of Orange County patients who need compounded medications themselves
• Patients who split time between California and another state

The pharmacy is PCAB accredited and USP 800 compliant, both current and verifiable standards, which stands in contrast to the lapsed-PCAB confusion discussed earlier. It also uses independent third-party testing and sources high-grade chemicals from FDA-inspected and cleared vendors.

Its core capabilities overlap with the needs Harbor serves:

• Bioidentical hormone replacement therapy (BHRT), with formulas adjustable at each refill based on lab results
• Pediatric formulations in kid-friendly forms and flavors, from newborns through teens
• Pain management topicals designed to localize treatment and reduce systemic side effects
• Dermatology preparations for acne, rosacea, eczema, psoriasis, scarring, and aging
• GLP-1 and peptide support and sports medicine formulations

Turnaround is typically one to two business days, with same-day pickup available for some medications.

The broader market shows why this matters. IBISWorld estimates the U.S. compounding pharmacy industry at $20.2 billion in 2026, and hormone replacement therapy is cited as the leading therapeutic segment with roughly 33.9% share. Other research firms estimate smaller figures depending on scope and methodology, but all point to strong, legitimate demand for the kind of personalized medication both pharmacies provide.

Conclusion: Verify First, Then Trust

The core findings are straightforward:

• Address: Harbor’s own current contact page points to 3500 W Lake Center Drive, Unit B, Santa Ana, while most third-party directories still list the older 2000 Harbor Blvd address in Costa Mesa. Always confirm directly by calling (949) 642-0106 before mailing documents or prescriptions.
• Accreditation: Harbor’s PCAB accreditation lapsed after December 2018 despite ongoing claims on its website, and NABP accreditation followed in 2022. Ask for current proof either way.
• Regulation: California’s October 2025 rule adds a new documentation layer that every compounding patient in Orange County should understand when filling a prescription today.

This was a verification guide, not a sales pitch. Nationwide Compounding Rx® is transparent that it does not currently serve California patients directly.

Have Questions About Compounding Standards or Need Service in Another State?

Readers outside California, and providers evaluating multi-state compounding partners, can explore Nationwide Compounding Rx®’s accreditation details and state-by-state shipping map on its website.

Healthcare providers can use the Provider Portal to begin a partnership inquiry built around the company’s Connect → Collaborate → Create → Care process, submitting and managing prescriptions directly with the pharmacy team.

Patients and families in eligible states can reach out through the website contact form or call (480) 499-8379, Monday through Friday, 7:00 AM to 3:30 PM, with questions about PCAB accreditation, USP 800 compliance, or specific formulation needs. Email inquiries receive a response within one business day.